XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements
 3 Months Ended 6 Months Ended
Jun. 30, 2023
shares
Jun. 30, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Jeff Ajer [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the three months ended June 30, 2023, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of BioMarin securities set forth in the table below.
Type of Trading Arrangement
NamePositionActionAdoption/Termination
Date		Rule 10b5-1*Non-
Rule 10b5-1**		Total Shares of Common Stock to be Sold***Expiration Date
Jeff AjerExecutive Vice President, Chief Commercial OfficerAdoptionApril 13, 2023X
up to 77,259
July 12, 2024

*    Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
**     “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
***    Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan.
Name Jeff Ajer  
Title Executive Vice President, Chief Commercial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date April 13, 2023  
Arrangement Duration 456 days  
Aggregate Available 77,259 77,259